Armistice Capital, LLC Ptc Therapeutics, Inc. Transaction History

Armistice Capital, LLC

  • $6.51 Billion
  • Q3 2025

A detailed history of Armistice Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 3,277,272 shares of PTCT stock, worth $247 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares
3,277,272
Previous 4,735,464 30.79%
Holding current value
$247 Million
Previous $231 Million 13.04%
% of portfolio
3.09%
Previous 4.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$43.3 - $62.88 $63.1 Million - $91.7 Million
-1,458,192 Reduced 30.79%
3,277,272 $201 Million
Q2 2025

Aug 14, 2025
SELL
$36.19 - $52.13 $25.3 Million - $36.5 Million
-699,379 Reduced 12.87%
4,735,464 $231 Million
Q1 2025

May 15, 2025
SELL
$41.81 - $57.17 $39.4 Million - $53.9 Million
-943,157 Reduced 14.79%
5,434,843 $277 Million
Q4 2024

Feb 14, 2025
SELL
$34.99 - $52.07 $30 Million - $44.6 Million
-856,898 Reduced 11.84%
6,378,000 $288 Million
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $8.29 Million - $10.3 Million
272,671 Added 3.92%
7,234,898 $268 Million
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $4.89 Million - $7.95 Million
198,227 Added 2.93%
6,962,227 $213 Million
Q1 2024

May 15, 2024
SELL
$24.15 - $31.95 $2.42 Million - $3.2 Million
-100,000 Reduced 1.46%
6,764,000 $197 Million
Q4 2023

Feb 13, 2024
BUY
$18.07 - $29.37 $12.9 Million - $21 Million
714,000 Added 11.61%
6,864,000 $189 Million
Q3 2023

Nov 14, 2023
BUY
$22.41 - $41.99 $65.3 Million - $122 Million
2,914,000 Added 90.05%
6,150,000 $138 Million
Q2 2023

Aug 14, 2023
BUY
$40.4 - $59.1 $12.6 Million - $18.4 Million
312,000 Added 10.67%
3,236,000 $132 Million
Q1 2023

May 15, 2023
SELL
$38.16 - $48.86 $18 Million - $23.1 Million
-472,000 Reduced 13.9%
2,924,000 $142 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $16.6 Million - $27.2 Million
496,000 Added 17.1%
3,396,000 $130 Million
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $16.6 Million - $21.3 Million
-396,000 Reduced 12.01%
2,900,000 $146 Million
Q2 2022

Aug 15, 2022
BUY
$25.6 - $45.23 $6.66 Million - $11.8 Million
260,000 Added 8.56%
3,296,000 $132 Million
Q1 2022

May 16, 2022
BUY
$33.33 - $44.6 $70.6 Million - $94.5 Million
2,118,893 Added 231.04%
3,036,000 $113 Million
Q4 2021

Feb 14, 2022
SELL
$35.36 - $41.86 $59.4 Million - $70.3 Million
-1,678,893 Reduced 64.67%
917,107 $36.5 Million
Q3 2021

Nov 15, 2021
BUY
$37.01 - $44.74 $18.7 Million - $22.5 Million
504,000 Added 24.09%
2,596,000 $96.6 Million
Q2 2021

Aug 16, 2021
BUY
$37.95 - $49.37 $26.4 Million - $34.4 Million
696,000 Added 49.86%
2,092,000 $88.4 Million
Q1 2021

May 17, 2021
BUY
$46.8 - $68.92 $31.8 Million - $46.9 Million
680,000 Added 94.97%
1,396,000 $66.1 Million
Q4 2020

Feb 16, 2021
SELL
$47.96 - $67.64 $383,680 - $541,120
-8,000 Reduced 1.1%
716,000 $43.7 Million
Q3 2020

Nov 16, 2020
BUY
$45.41 - $57.07 $10.2 Million - $12.8 Million
224,000 Added 44.8%
724,000 $33.8 Million
Q2 2020

Aug 14, 2020
SELL
$42.56 - $54.98 $4.26 Million - $5.5 Million
-100,000 Reduced 16.67%
500,000 $25.4 Million
Q1 2020

May 15, 2020
SELL
$32.37 - $59.36 $5.11 Million - $9.38 Million
-158,000 Reduced 20.84%
600,000 $26.8 Million
Q4 2019

Feb 14, 2020
BUY
$32.22 - $50.07 $20 Million - $31.1 Million
622,000 Added 457.35%
758,000 $36.4 Million
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $4.6 Million - $6.55 Million
136,000 New
136,000 $4.6 Million
Q2 2019

Aug 14, 2019
SELL
$35.42 - $45.0 $14.2 Million - $18 Million
-400,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$28.09 - $39.49 $2.81 Million - $3.95 Million
100,000 Added 33.33%
400,000 $15.1 Million
Q4 2018

Feb 14, 2019
BUY
$29.83 - $46.51 $8.95 Million - $14 Million
300,000 New
300,000 $10.3 Million

Others Institutions Holding PTCT

# of Institutions
325
Shares Held
83.2M
Call Options Held
811K
Put Options Held
207K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $5.39B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email